The 2026 acne-trial protocol adds oral probiotics and a topical secretome to standard therapy to test safety and skin response. Secretome means the mixture cells release that is applied to skin, and the main questions are irritation, dryness and added gut or redness effects. BMJ Open describes an 8-week double-blind trial with four groups and pre/post acne and microbiome checks in the published protocol. All groups use once-nightly clindamycin-plus-tretinoin on affected areas plus structured skincare.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does each group receive?
- Which reactions come from the standard cream?
- What safety signals exist for the add-ons?
- How can acne-prone skin limit irritation?
What does each group receive?
The oral product is HEXBIO. It contains Lactobacillus acidophilus BCMC 12130, L. casei BCMC 12313, Lactococcus lactis BCMC 12451, Bifidobacterium bifidum BCMC 02290, B. longum BCMC 02120 and B. infantis strains.
The protocol gives it as a daily capsule alongside skin care. The trial registry NCT06925386 lists the same four options. Participants receive standard therapy plus probiotic plus secretome, standard therapy plus probiotic alone, standard therapy plus secretome alone, or standard therapy plus double placebo. This design separates active adjuncts from placebo adjuncts. Standard therapy means the same base for every arm. It includes clindamycin-plus-tretinoin cream at night only on acne-affected areas plus a set cleansing and moisturizing routine.
Which reactions come from the standard cream?
The retinoid-antibiotic combination irritates acne-prone skin. FDA labeling warns it commonly causes dryness, peeling, redness, burning, stinging or itching in the clindamycin-tretinoin label.
These effects often peak during early weeks and then ease. Watch for these warning signs during nightly use: Apply a thin layer only where directed. More cream does not clear acne faster and raises irritation risk.
- new dryness, peeling, redness, burning, stinging or itching
- severe redness, swelling, blistering or crusting that means stop and call a doctor
- spreading irritation beyond treated spots after thin, area-only application
What safety signals exist for the add-ons?
A Medicina systematic review of double-blind acne probiotic trials found no serious adverse events in the December 2025 review. Mild gut symptoms occurred in under 5% of participants at similar rates in probiotic and control groups. That pattern points to low added gut risk at similar doses. Topical secretome data in acne remain limited.
A Life 2025 case series of needle radiofrequency with topical exosomes for moderate-to-severe acne reported minimal adverse effects, with mild post-procedure redness resolving about 45 minutes after application. That setting differs from daily secretome use without a procedure. FDA states there are currently no FDA-approved exosome products and warns that clinics marketing them for disease treatment make unsubstantiated claims in the agency safety notice. Treat secretome marketing claims with caution and judge only trial-measured acne and microbiome results.
How can acne-prone skin limit irritation?
Keep the routine gentle while using the night cream. The American Medical Association, quoting an AAD dermatologist, advises gentle alcohol-free cleansing, oil-free non-comedogenic moisturizer and broad-spectrum SPF 30+ without scrubbing. This matters most during the irritating first weeks of retinoid-antibiotic treatment.
Use lukewarm water and fingertips, then pat dry. Apply moisturizer to damp skin and use sunscreen each morning. Avoid scrubs, astringents, picking and new exfoliating products until skin settles.
You Might Also Like
- Skin Microbiome Outcomes in the 2026 Probiotic Acne Review: Safety and Skin-Reaction Questions for People With Acne-Prone Skin
- Probiotics for Acne in a 2026 Systematic Review and Meta-Analysis: Safety and Skin-Reaction Questions for People With Acne-Prone Skin
- Low-Dose Isotretinoin Side Effects in the 2026 Fish Oil Trial: Safety and Monitoring Questions for Adults With Persistent Acne